Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines

27Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The transcription factor NF-κB plays an important role in the regulated expression of cytokines in human monocytes. A p100 subunit of NF-κB has IκB-like properties by sequestering the p65 transactivating subunit in the cytosol of cells. In transient transfection assays we demonstrated that p100 has an inhibitory effect on the NF-κB-dependent IL-6 promoter activity. In view of this finding, we studied the regulation of the p100 subunit in human monocytes in response to LPS, the inflammatory cytokines IL-1β and TNF-α and lymphokines. The results demonstrate that LPS, IL-1β, and TNF-α induce p100 expression at mRNA and protein level while IFN-γ, IL-3 and IL-4/IL-10 have no effect. The induction of p100 expression was shown to be mediated by a two-fold increase in the p100 transcription rate and a two-fold increase in p100 mRNA stability. Furthermore the p100 mediated upregulation was dependent on a tyrosine kinase dependent pathway rather than the protein kinase C pathway. NF-κB is a complex of either p50 homodimers or a p50/p65 heterodimer. The latter is known to strongly autoregulate p100 transcription. We therefore examined the composition of NF-κB induced by LPS vs the different lymphokines. LPS-induced NF-κB showed a distinct p65 supershift whereas the composition of NF-κB induced by different lymphokines did not show a change in p65. We conclude that the p100 subunit of the transcription factor NF-κB is induced by different inflammatory mediators while lymphokines fail to induce p100 expression which may be caused by the induction of NF-κB predominantly consisting of p50 homodimers.

Cite

CITATION STYLE

APA

De Wit, H., Dokter, W. H. A., Koopmans, S. B., Lummen, C., Van Der Leij, M., Smit, J. W., & Vellenga, E. (1998). Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines. Leukemia, 12(3), 363–370. https://doi.org/10.1038/sj.leu.2400950

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free